SCHEMBL3762907

SCHEMBL3762907

COc1cccc(C(=O)NC2CCN(CC(=O)N3CCN(C4CCC4)CC3)C2)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 5/20 0.58
ALDH1A1 P00352 4/20 0.56
TSHR P16473 1/20 0.56
KMT2A Q03164 5/20 0.55
LMNA P02545 1/20 0.53
MEN1 O00255 3/20 0.51
POLB P06746 2/20 0.51
KDM4E B2RXH2 2/20 0.51
USP2 O75604 1/20 0.51
CYP1A2 P05177 1/20 0.51
HSP90AA1 P07900 1/20 0.51
HSP90AB1 P08238 1/20 0.51
HSPA1A P0DMV8 1/20 0.51
CYP2D6 P10635 1/20 0.51
MAPT P10636 1/20 0.51
CYP2C9 P11712 1/20 0.51
NR4A1 P22736 1/20 0.51
CYP2C19 P33261 1/20 0.51
PTPN7 P35236 1/20 0.51
RAB9A P51151 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3765339 0.91 HPGD (0.56) MCHR1ALDH1A1TSHRKMT2ALMNA
SCHEMBL3780573 0.90 PKM (0.54) MCHR1ALDH1A1KMT2AMEN1POLB
SCHEMBL3776073 0.89 KMT2A (0.70) MCHR1ALDH1A1TSHRKMT2AMEN1
SCHEMBL3762917 0.88 USP2 (0.52) ALDH1A1KMT2ALMNAMEN1POLB
SCHEMBL3774004 0.85 DRD2 (0.51) MCHR1ALDH1A1KMT2AMEN1POLB
SCHEMBL3774792 0.85 HPGD (0.60) MCHR1ALDH1A1TSHRKMT2ALMNA
SCHEMBL3767649 0.84 DRD4 (0.56) MCHR1
SCHEMBL3767492 0.84 HRH3 (0.53) MCHR1ALDH1A1KMT2APOLBCYP2D6
SCHEMBL3768127 0.83 KMT2A (0.54) ALDH1A1KMT2ALMNAKDM4ERAB9A
SCHEMBL3779258 0.83 KMT2A (0.51) KMT2AMEN1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7851474-B2 Dipiperazinyl ketones and related analogues NEUROGEN CORPORATION (US) 2010-12-14 US disclosed
US-7851474-B2 Dipiperazinyl ketones and related analogues NEUROGEN CORPORATION (US) 2010-12-14 US disclosed
US-7851474-B2 Dipiperazinyl ketones and related analogues NEUROGEN CORPORATION (US) 2010-12-14 US disclosed
US-20070049571-A1 Dipiperazinyl ketones and related analogues NEUROGEN CORPORATION 2007-03-01 US disclosed
US-20070049571-A1 Dipiperazinyl ketones and related analogues NEUROGEN CORPORATION 2007-03-01 US disclosed
US-20070049571-A1 Dipiperazinyl ketones and related analogues NEUROGEN CORPORATION 2007-03-01 US disclosed
WO-2007016496-A2 DIPIPERAZINYL KETONES AND RELATED ANALOGUES NEUROGEN CORPORATION (US) 2007-02-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070049571-A1 Dipiperazinyl ketones and related analogues HRH4, HRH3, HRH1 MCHR1 239/4885ALDH1A1 1210/4885TSHR 436/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.